Clinical Trial: A Study of BL-M09D1 in Patients With Locally Advanced or Metastatic Gynecological Malignancies and Other Solid Tumors

U.S., Aug. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07769229) titled 'A Study of BL-M09D1 in Patients With Locally Advanced or Metastatic Gynecological Malignancies and Other Solid Tumors' on Aug. 12.

Brief Summary: This study is a single-arm, open-label, multicenter, non-randomized phase II clinical study evaluating the efficacy and safety of BL-M09D1 for injection in patients with locally advanced or metastatic gynecological malignancies and other solid tumors.

Study Start Date: Aug., 2026

Study Type: INTERVENTIONAL

Condition: Gynecological Malignancies Solid Tumors

Intervention: DRUG: BL-M09D1

Administration by intravenous infusion for a cycle of 3 weeks.

Recruitment Status: NOT_YET_RECRUIT...